CAS Insight

The 27 Lead Drug Molecules Acquired from Biotechs in 2021

Our team conducted a review of all  the biotech acquisitions of 2021 and distilled it down to the acquisitions of drug discovery-focused biotechs. 

Navigate the 2021 M&A Series

Here, we provide a comprehensive overview of the full series, including a PDF poster book; a complete list of the acquired lead molecules with disclosed structures that were acquired in 2021, with an accompanying deep-dive slide deck; a complete list of acquisitions of biotech companies focused on molecular drug discovery in 2021, with an accompanying deep-dive slide deck; and finally an interactive table of all the biotech acquisitions of 2021. 

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more:

Join the Drug Hunter mailing list

to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.


Join Subscribers from

…and hundreds more!